Examkin

Question

Difficulty: MediumSubstance-Related and Addictive Disorders

A 24-year-old woman is brought to the emergency department by her friends due to severe agitation, confusion, and high fever. The friends report that she was at an electronic dance music festival earlier in the evening where she ingested a "party pill." Her medical history is notable for treatment-resistant depression, for which she currently takes tranylcypromine. Her temperature is 39.8°C (103.6°F), blood pressure is 165/95 mmHg, and pulse is 128/min. Physical examination shows pronounced diaphoresis, dilated pupils, generalized hyperreflexia, and bilateral ankle clonus. Bowel sounds are hyperactive. Which of the following substances did this patient most likely ingest?

  1. 3,4-methylenedioxymethamphetamineAnswer
  2. B
    Cocaine
  3. C
    Phencyclidine
  4. D
    Heroin
  5. E
    Synthetic cannabinoids

Answer

The correct answer is 3,4-methylenedioxymethamphetamine (MDMA), which precipitated serotonin syndrome due to its interaction with the patient's MAOI.
The correct answer is 3,4-methylenedioxymethamphetamine (MDMA). This patient's presentation of severe autonomic instability (hyperthermia, hypertension, tachycardia), altered mental status (agitation, confusion), and distinct neuromuscular hyperactivity (hyperreflexia, bilateral ankle clonus) is classic for serotonin syndrome. MDMA is a synthetic amphetamine derivative commonly used as a club drug that triggers a massive release of serotonin, dopamine, and norepinephrine into the synaptic cleft. Tranylcypromine is a monoamine oxidase inhibitor (MAOI) that blocks the degradation of monoamines, including serotonin. The combination of a massive serotonin releaser (MDMA) and an MAOI (tranylcypromine) creates a dangerous, potentially fatal pharmacokinetic interaction resulting in excessive synaptic serotonin and severe serotonin syndrome. The presence of clonus and hyperreflexia are the key differentiating features that separate serotonin syndrome from other toxidromes.

Step-by-Step Solution

1
Identify the primary toxidrome from the physical examination and vital signs.
The patient has hyperthermia, hypertension, tachycardia, altered mental status, generalized hyperreflexia, ankle clonus, and hyperactive bowel sounds.
Recognizing the triad of autonomic instability, altered mental status, and neuromuscular irritability (specifically clonus and hyperreflexia) is essential to diagnose serotonin syndrome.
2
Analyze the patient's medication history for potential pharmacological interactions.
The patient is taking tranylcypromine, a monoamine oxidase inhibitor (MAOI).
MAOIs inhibit the breakdown of monoamines, greatly increasing the risk of serotonin syndrome when combined with serotonergic agents.
3
Determine which illicit substance would interact with the MAOI to produce the observed toxidrome.
3,4-methylenedioxymethamphetamine (MDMA) acts as a massive serotonin releaser. When combined with an MAOI, it prevents serotonin breakdown, leading to life-threatening serotonin syndrome.
Connecting the club drug exposure to its pharmacological mechanism identifies MDMA as the culprit.

Key Concept

Combining a monoamine oxidase inhibitor (MAOI) with a strong serotonergic agent like MDMA can precipitate life-threatening serotonin syndrome, characterized by autonomic instability, altered mental status, and neuromuscular irritability (e.g., hyperreflexia, clonus).
Rate this question

Topics

Substance-Related and Addictive Disorders

More questions from this topic